MOLLY PETERSEN: Open Payments
NPI 1679987432 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 85 payments from 14 companies in 2025. Trend: 2023 $1,527 · 2024 $1,169 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $215 |
| Lundbeck LLC | 18 | $187 |
| Collegium Pharmaceutical, Inc. | 21 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $136 |
| Supernus Pharmaceuticals, Inc. | 6 | $128 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, Jornay PM, CAPLYTA, Qelbree, Auvelity, HETLIOZ, Quviviq.
Industry payments across NE — which companies pay providers there.
